Antisense protein kinase A RIα inhibits 7,12-dimethylbenz(a) anthracene-induction mammary cancer: Blockade at the initial phase of carcinogenesis

Clinical Cancer Research

Volumn 10, Issue 13, 2004, Pages 4568-4577

  Nesterova, Maria V ^a   Cho Chung, Yoon S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE RIALPHA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLUTATHIONE TRANSFERASE; OXIDOREDUCTASE; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INHIBITION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DNA REPAIR; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; LIVER; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TUMOR GROWTH;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CATALYTIC DOMAIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ETHANOLAMINES; FEMALE; GLUTATHIONE TRANSFERASE; IMMUNOPRECIPITATION; LIVER; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; NAD(P)H DEHYDROGENASE (QUINONE); NADPH DEHYDROGENASE; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 3042770595     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0436     Document Type: Article

References (52)

1. Wattenberg LW. Inhibition of neoplasia by minor dietary constituents. Cancer Res 1983;43:2448s-53s.
2. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985;45: 1-8.
3. Talalay P, De Long MJ, Prochaska HJ. Molecular mechanisms in protection against carcinogenesis. In: Cory JG, Szentivani A, editors. Cancer biology and therapeutics. New York: Plenum Press; 1987. p. 197-216.
4. Talalay P, Batzinger RP, Benson AM, Bueding E, Cha YN. Biochemical studies on the mechanisms by which dietary antioxidants suppress mutagenic activity. Adv Enzyme Regul 1978;17:23-36.
5. Zedeck MS, Lipkin M. Inhibition of tumor induction and development: chemical and immunological approaches. New York: Plenum Press; 1981.
6. Cho-Chung YS, Clair T, Shepheard C. Anticarcinogenic effect of N6,O2-dibutyryl cyclic adenosine 3′,5′-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3′,5′-monophosphate metabolism and protein kinase. Cancer Res 1983;43:2736-40.
7. Mizuno T, Chou MY, Inouye M. A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA). Proc Natl Acad Sci USA 1984;81:1966-70.
8. Heywood SM. tcRNA as a naturally occurring antisense RNA in eukaryotes. Nucleic Acids Res 1986;14:6771-2.
9. Agrawal S. Antisense oligonucleotides: towards clinical trials. Trends Biotechnol 1996;14:376-87.
10. Stein CA, Krieg AM. Applied antisense oligonucleotide technology. Somereset, NJ: Wiley-Liss, Inc.; 1998.
11. Gewirtz AM. Oligonucleotide therapeutics: a step forward. J Clin Oncol 2000;18:1809-11.
12. Cho-Chung YS. Antisense DNAs as targeted therapeutics for cancer: no longer a dream. Curr Opin Investig Drug 2002;3:934-9.
13. Bielinska A, Shivdasani RA, Zhang LQ, Nabel GJ. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science (Wash DC) 1990;250:997-1000.
14. Clowes AW, Clowes MM. Inhibition of smooth muscle cell proliferation by heparin molecules. Transplant Proc 1989;21:3700-1.
15. Nesterova M, Cho-Chung YS. A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth. Nat Med 1995;1:528-633.
16. Park YG, Nesterova M, Agrawal S, Cho-Chung YS. Dual blockade of cyclic AMP response element (CRE)- and AP-1-directed transcription by CRE transcription factor decoy oligonucleotide: gene-specific inhibition of tumor growth. J Biol Chem 1999;274:1573-80.
17. Cho-Chung YS. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res 1990;50:7093-100.
18. Cho-Chung YS, Pepe S, Clair T, Budillon A, Nesterova M. cAMP-dependent protein kinase: role in normal and malignant growth. Crit Rev Oncol Hematol 1995;21:33-61.
19. Tortora G, Ciardiello F. Protein kinase A as target for novel integrated strategies of cancer therapy. Ann NY Acad Sci 2002;968: 139-47.
20. Cho-Chung YS. Antisense and therapeutic oligonucleotides: toward a gene-targeting cancer clinic. Exp Opin Ther Patents 2000;10:1711-24.
21. Cho-Chung YS, Nesterova M, Pepe S, et al. Antisense DNA-targeting protein kinase A-RIα subunit: a novel approach to cancer treatment. Front Biosci 1999;4:D898-907.
22. Nesterova M, Cho-Chung YS. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit. Antisense Nucleic Acid Drug Dev 2000;10:423-33.
23. Cho-Chung YS, Nesterova M, Kondrashin A, Noguchi K, Srivastava RK, Pepe S. Antisense-protein kinase A: a single-gene-based therapeutic approach. Antisense Nucleic Acid Drug Dev 1997;7: 217-23.
24. Wang H, Cai Q, Zeng X, Yu D, Agrawal S, Zhang MQ. Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci USA 1999;96:13989-94.
25. Dipple A, Pigott M, Moschel RC, Costantino N. Evidence that binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Cancer Res 1983;43:4132-5.
26. Sawicki JT, Moschel RC, Dipple A. Involvement of both syn- and anti-dihydrodiol-epoxides in the binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse embryo cell cultures. Cancer Res 1983;43: 3212-8.
27. Moschel RC, Pigott MA, Costantino N, Dipple A. Chromatographic and fluorescence spectroscopic studies of individual 7,12-dimethylbenz[a]anthracene- deoxyribonucleoside adducts. Carcinogenesis (Lond) 1983;4:1201-4.
28. Benson AM, Batzinger RP, Ou SY, Bueding E, Cha YN, Talalay P. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res 1978;38:4486-95.
29. Benson AM, Hunkeler MJ, Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 1980;77: 5216-20.
30. Sparnins VL, Chuan J, Wattenberg LW. Enhancement of glutathione S-transferase activity of the esophagus by phenols, lactones, and benzyl isothiocyanate. Cancer Res 1982;42:1205-7.
31. Liu B, Cvijic ME, Jetzt A, Chin KV. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants. Cell Growth Differ 1996;7:1105-12.
32. Agrawal S, Jiang Z, Zhao Q, et al. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Proc Natl Acad Sci USA 1997;94:2620-5.
33. Lowry OH, Passonneau JV. Kinetic evidence for multiple binding sites on phosphofructokinase. J Biol Chem 1966;241:2268-79.
34. Kim SN, Lee GR, Cho-Chung YS, Park SD, Hong SH. Overexpression of RIIβ regulatory subunit of protein kinase A induces growth inhibition and reverse-transformation in SK-N-SH human neuroblastoma cells. Int J Oncol 1996;8:663-8.
35. Prochaska HJ, Santamaria AB. Direct measurement of NAD(P)H: quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem 1988;169: 328-36.
36. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
37. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-89.
38. Fried M, Crothers DM. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 1981;9:6505-25.
39. Chu G, Chang E. Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc Natl Acad Sci USA 1990;87:3324-8.
40. Maltzman TH, Christou M, Gould MN, Jefcoate CR. Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on Phase I hepatic metabolizing enzymes. Carcinogenesis (Lond) 1991;12:2081-7.
41. Huggins C, Pataki J. Aromatic azo derivatives preventing mammary cancer and adrenal injury from 7,12-dimethylbenz(a)anthracene. Proc Natl Acad Sci USA 1965;53:791-6.
42. Prochaska HJ, De Long MJ, Talalay P. On the mechanisms of induction of cancer-protective enzymes: a unifying proposal. Proc Natl Acad Sci USA 1985;82:8232-6.
43. De Long MJ, Prochaska HJ, Talalay P. Induction of NAD(P)H: quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. Proc Natl Acad Sci USA 1986;83:787-91.
44. Herzfeld A, Greengard O. The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res 1977;37:231-8.
45. Ip C, Lisk DJ. Modulation of Phase I and Phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats. Nutr Cancer 1997;28:184-8.
46. Friling RS, Bergelson S, Daniel V. Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene. Proc Natl Acad Sci USA 1992;15: 668-72.
47. Roesler WJ, Vandenbark GR, Hanson RW. Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 1988;263: 9063-6.
48. Neary CL, Cho-Chung YS. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit. Oncogene 2001;20: 8019-24.
49. Guengerich FP. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 1988;48: 2946-54.
50. Kapitulnik J, Wislocki PG, Levin W, et al. Marked differences in the carcinogenic activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8- dihydrobenzo(a)pyrene in newborn mice. Cancer Res 1978; 38:2661-5.
51. Radjendirane V, Joseph P, Jaiswal AK. Gene expression of DT-diaphorase (NQO1) in cancer cells. In: Henry JF, Enrique C, editors. Oxidative stress and signal transduction, New York: Chapman & Hall; 1997. p. 441-75.
52. O'Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 1991;80:1-41.